{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:13:39Z","timestamp":1792725219432,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["23S21900800"],"award-info":[{"award-number":["23S21900800"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["23S11901300"],"award-info":[{"award-number":["23S11901300"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373274"],"award-info":[{"award-number":["82373274"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["202240370"],"award-info":[{"award-number":["202240370"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["2024ZZ1009"],"award-info":[{"award-number":["2024ZZ1009"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.drudis.2026.104609","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:45:20Z","timestamp":1769013920000},"page":"104609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Achieving durable psoriasis remission with nucleic acid therapeutics"],"prefix":"10.1016","volume":"31","author":[{"given":"Hanxue","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaye","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quangang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3789-7096","authenticated-orcid":false,"given":"Zhongjian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2026.104609_b0005","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.drudis.2026.104609_b0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S2213-8587(21)00045-0","article-title":"Epidemiology and determinants of obesity in China","volume":"9","author":"Pan","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.drudis.2026.104609_b0015","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1038\/s41467-025-56719-8","article-title":"GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets","volume":"16","author":"Dand","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104609_b0020","doi-asserted-by":"crossref","first-page":"17041","DOI":"10.1039\/C9NR06303J","article-title":"Transdermal delivery of small interfering RNAs with topically applied mesoporous silica nanoparticles for facile skin cancer treatment","volume":"11","author":"Lio","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.drudis.2026.104609_b0025","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1478-811X-11-88","article-title":"Exosomes are natural carriers of exogenous siRNA to human cells in vitro","volume":"11","author":"Shtam","year":"2013","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.drudis.2026.104609_b0030","doi-asserted-by":"crossref","DOI":"10.1515\/med-2024-1049","article-title":"Role of FOXM1 and AURKB in regulating keratinocyte function in psoriasis","volume":"19","author":"Zhao","year":"2024","journal-title":"Open Med"},{"key":"10.1016\/j.drudis.2026.104609_b0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","article-title":"Advances in the pathogenesis of psoriasis: from keratinocyte perspective","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.drudis.2026.104609_b0040","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jconrel.2017.10.034","article-title":"Using siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation in psoriasis","volume":"268","author":"Nemati","year":"2017","journal-title":"J Control Release"},{"key":"10.1016\/j.drudis.2026.104609_b0045","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/jid.2011.55","article-title":"MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2","volume":"131","author":"Xu","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.drudis.2026.104609_b0050","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/jcp.22872","article-title":"Lithium regulates keratinocyte proliferation via glycogen synthase kinase 3 and NFAT2 (nuclear factor of activated T cells 2)","volume":"227","author":"Hampton","year":"2012","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.drudis.2026.104609_b0055","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jconrel.2023.12.009","article-title":"Transdermal delivery of Fn14 siRNA using a novel composite ionic liquid for treatment of psoriasis-like skin lesions","volume":"365","author":"Li","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.drudis.2026.104609_b0060","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jid.2022.12.028","article-title":"Eukaryotic initiation factor 4E (eIF4E) as a target of anti-psoriatic treatment","volume":"144","author":"Golob-Schwarzl","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.drudis.2026.104609_b0065","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ajpath.2023.01.016","article-title":"Protein kinase CK2 promotes proliferation, abnormal differentiation, and proinflammatory cytokine production of keratinocytes via regulation of STAT3 and Akt pathways in psoriasis","volume":"193","author":"Huang","year":"2023","journal-title":"Am J Pathol"},{"key":"10.1016\/j.drudis.2026.104609_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0279908","article-title":"The study of GSDMB in pathogenesis of psoriasis vulgaris","volume":"18","author":"Ji","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2026.104609_b0075","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10616-021-00496-x","article-title":"Circ-IGF1R plays a significant role in psoriasis via regulation of a miR-194-5p\/CDK1 axis","volume":"73","author":"Fang","year":"2021","journal-title":"Cytotechnology"},{"key":"10.1016\/j.drudis.2026.104609_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcp.2022.101803","article-title":"LncRNA AGXT2L1-2:2 facilitates keratinocytes proliferation and inhibits apoptosis by interacting with estrogen-related receptor alpha in psoriasis","volume":"62","author":"Wang","year":"2022","journal-title":"Mol Cell Probes"},{"key":"10.1016\/j.drudis.2026.104609_b0085","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jid.2018.06.184","article-title":"Cornulin is induced in psoriasis lesions and promotes keratinocyte proliferation via phosphoinositide 3-kinase\/Akt pathways","volume":"139","author":"Li","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.drudis.2026.104609_b0090","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/bjd.14481","article-title":"Zinc finger protein A20 is involved in the antipsoriatic effect of calcipotriol","volume":"175","author":"Liu","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.drudis.2026.104609_b0095","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/cpr.12168","article-title":"IFI27, a novel epidermal growth factor-stabilized protein, is functionally involved in proliferation and cell cycling of human epidermal keratinocytes","volume":"48","author":"Hsieh","year":"2015","journal-title":"Cell Prolif"},{"key":"10.1016\/j.drudis.2026.104609_b0100","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202345","article-title":"Single-cell analysis of human skin identifies CD14+ type 3 dendritic cells co-producing IL1B and IL23A in psoriasis","volume":"218","author":"Nakamizo","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.drudis.2026.104609_b0105","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/jdv.16273","article-title":"The role of the interleukin-23\/Th17 pathway in cardiometabolic comorbidity associated with psoriasis","volume":"34","author":"Egeberg","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.drudis.2026.104609_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115898","article-title":"The role of NLRP1, NLRP3, and AIM2 inflammasomes in psoriasis: review","volume":"22","author":"Ci\u0105\u017cy\u0144ska","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2026.104609_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14715\/cmb\/2023.69.12.1","article-title":"ErbB4 affects Th1\/Th17 cell differentiation and promotes psoriasis progression","volume":"69","author":"Tang","year":"2023","journal-title":"Cell Mol Biol"},{"key":"10.1016\/j.drudis.2026.104609_b0120","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1177\/1535370221993424","article-title":"Inhibition of phospholipases suppresses progression of psoriasis through modulation of inflammation","volume":"246","author":"Gao","year":"2021","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.drudis.2026.104609_b0125","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1097\/CM9.0000000000001197","article-title":"Small interfering RNA targeting of keratin 17 reduces inflammation in imiquimod-induced psoriasis-like dermatitis","volume":"133","author":"Xiao","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.drudis.2026.104609_b0130","doi-asserted-by":"crossref","first-page":"E5825","DOI":"10.1073\/pnas.1509971112","article-title":"I\u03baB\u03b6 is a key driver in the development of psoriasis","volume":"112","author":"Johansen","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2026.104609_b0135","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jid.2023.07.006","article-title":"IL-22-induced ubiquitin-specific protease 15 promotes proliferation and inflammation of keratinocytes through stabilization of squamous cell carcinoma antigen 2","volume":"144","author":"Chen","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.drudis.2026.104609_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116746","article-title":"Centella asiatica alleviates psoriasis through JAK\/STAT3-mediated inflammation: an in vitro and in vivo study","volume":"317","author":"Lin","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.drudis.2026.104609_b0145","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","article-title":"Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis","volume":"397","author":"Ghoreschi","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2026.104609_b0150","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2217\/imt-2018-0131","article-title":"Biologics switch in psoriasis","volume":"11","author":"Wang","year":"2019","journal-title":"Immunotherapy"},{"key":"10.1016\/j.drudis.2026.104609_b0155","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clim.2016.03.009","article-title":"Treating psoriasis by targeting its susceptibility gene Rel","volume":"165","author":"Fan","year":"2016","journal-title":"Clin Immunol"},{"key":"10.1016\/j.drudis.2026.104609_b0160","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jconrel.2021.08.039","article-title":"TNF\u03b1 siRNA delivery by nanoparticles and photochemical internalization for psoriasis topical therapy","volume":"338","author":"Suzuki","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.drudis.2026.104609_b0165","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb6049","article-title":"Treatment of psoriasis with NFKBIZ siRNA using topical ionic liquid formulations","volume":"6","author":"Mandal","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.drudis.2026.104609_b0170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jid.2022.06.025","article-title":"KMT2C induced by FABP5P3 aggravates keratinocyte hyperproliferation and psoriasiform skin inflammation by upregulating the transcription of PIK3R3","volume":"143","author":"Huang","year":"2023","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.drudis.2026.104609_b0175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10142-023-01057-5","article-title":"Emerging roles of non-coding RNAs in psoriasis pathogenesis","volume":"23","author":"Ghosh","year":"2023","journal-title":"Funct Integr Genomics"},{"key":"10.1016\/j.drudis.2026.104609_b0180","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.immuni.2010.05.009","article-title":"Regulation of microRNA expression and abundance during lymphopoiesis","volume":"32","author":"Kuchen","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.drudis.2026.104609_b0185","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1016\/j.bbadis.2017.08.014","article-title":"miR-4516, a microRNA downregulated in psoriasis inhibits keratinocyte motility by targeting fibronectin\/integrin \u03b19 signaling","volume":"1863","author":"Chowdhari","year":"2017","journal-title":"Biochim Biophys Acta (BBA) \u2013 Mol Basis Dis"},{"key":"10.1016\/j.drudis.2026.104609_b0190","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/ijd.13102","article-title":"Increased micro RNA\u20101266 levels as a biomarker for disease activity in psoriasis vulgaris","volume":"55","author":"Seifeldin","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.drudis.2026.104609_b0195","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/exd.13888","article-title":"MiR-744-3p regulates keratinocyte proliferation and differentiation via targeting KLLN in psoriasis","volume":"28","author":"Wang","year":"2019","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.drudis.2026.104609_b0200","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s40291-021-00531-9","article-title":"Serum levels of miR-146a in patients with psoriasis","volume":"25","author":"Leal","year":"2021","journal-title":"Mol Diagn Therapy"},{"key":"10.1016\/j.drudis.2026.104609_b0205","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/jcp.27135","article-title":"Downregulated miR\u2010187 contributes to the keratinocytes hyperproliferation in psoriasis","volume":"234","author":"Tang","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.drudis.2026.104609_b0210","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/s41419-021-04230-5","article-title":"MiR-193b-3p-ERBB4 axis regulates psoriasis pathogenesis via modulating cellular proliferation and inflammatory-mediator production of keratinocytes","volume":"12","author":"Huang","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.drudis.2026.104609_b0215","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41419-018-0621-y","article-title":"MicroRNA-17-92 cluster promotes the proliferation and the chemokine production of keratinocytes: implication for the pathogenesis of psoriasis","volume":"9","author":"Zhang","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.drudis.2026.104609_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/etm.2021.10176","article-title":"miR\u2011489\u20113p inhibits TLR4\/NF\u2011\u03baB signaling to prevent inflammation in psoriasis","volume":"22","author":"Ye","year":"2021","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.drudis.2026.104609_b0225","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm0297-183","article-title":"Murine psoriasis-like disorder induced by naive CD4+ T cells","volume":"3","author":"Sch\u00f6n","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.drudis.2026.104609_b0230","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2013.10.009","article-title":"Up-regulation of microRNA-210 induces immune dysfunction via targeting FOXP3 in CD4(+) T cells of psoriasis vulgaris","volume":"150","author":"Zhao","year":"2014","journal-title":"Clin Immunol"},{"key":"10.1016\/j.drudis.2026.104609_b0235","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1172\/JCI97426","article-title":"MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation","volume":"128","author":"Wu","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.drudis.2026.104609_b0240","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202215674","article-title":"Metabolic rewiring in keratinocytes by miR-31-5p identifies therapeutic intervention for psoriasis","volume":"15","author":"Wang","year":"2023","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.drudis.2026.104609_b0245","doi-asserted-by":"crossref","first-page":"14030","DOI":"10.1073\/pnas.1111292109","article-title":"microRNA-31\/factor-inhibiting hypoxia-inducible factor 1 nexus regulates keratinocyte differentiation","volume":"109","author":"Peng","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2026.104609_b0250","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/bjd.21232","article-title":"miR-378a regulates keratinocyte responsiveness to interleukin-17A in psoriasis","volume":"187","author":"Xia","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.drudis.2026.104609_b0255","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.jaci.2020.12.657","article-title":"Cross-talk between IFN-\u03b3 and TWEAK through miR-149 amplifies skin inflammation in psoriasis","volume":"147","author":"Srivastava","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.drudis.2026.104609_b0260","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jconrel.2018.05.040","article-title":"Ultrasound targeting of Q-starch\/miR-197 complexes for topical treatment of psoriasis","volume":"284","author":"Lifshiz Zimon","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.drudis.2026.104609_b0265","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/bjd.17256","article-title":"Downregulation of miR-145-5p contributes to hyperproliferation of keratinocytes and skin inflammation in psoriasis","volume":"180","author":"Yan","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.drudis.2026.104609_b0270","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jaci.2016.07.025","article-title":"MicroRNA-146a suppresses IL-17-mediated skin inflammation and is genetically associated with psoriasis","volume":"139","author":"Srivastava","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.drudis.2026.104609_b0275","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.4049\/jimmunol.1800189","article-title":"miR-340 alleviates psoriasis in mice through direct targeting of IL-17A","volume":"201","author":"Bian","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.drudis.2026.104609_b0280","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008089","article-title":"Targeting miR-21 to treat psoriasis","volume":"6","author":"Guinea-Viniegra","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.drudis.2026.104609_b0285","article-title":"Small extracellular vesicles derived from MSCs have immunomodulatory effects to enhance delivery of ASO-210 for psoriasis treatment","volume":"10","author":"Zhang","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.drudis.2026.104609_b0290","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202403949","article-title":"Targeting the skin: the study of a bottlebrush polymer\u2010antisense oligonucleotide conjugate in a psoriasis mouse model","author":"Fang","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.drudis.2026.104609_b0295","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/1346-8138.15149","article-title":"Topical administration of nanocarrier miRNA\u2010210 antisense ameliorates imiquimod\u2010induced psoriasis\u2010like dermatitis in mice","volume":"47","author":"Feng","year":"2020","journal-title":"J Dermatol"},{"key":"10.1016\/j.drudis.2026.104609_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106314","article-title":"Transcutaneous amorphous preparation co-delivering curcumin and modified aptamer as a synergistic approach for the amelioration of psoriasis-like skin inflammation","volume":"180","author":"Jin","year":"2023","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.drudis.2026.104609_b0305","article-title":"Anti-IL-17A ssDNA aptamer ameliorated psoriasis skin lesions in the imiquimod-induced psoriasis mouse model","volume":"110","author":"Shobeiri","year":"2022","journal-title":"Inte Immunopharmacol"},{"key":"10.1016\/j.drudis.2026.104609_b0310","first-page":"1","article-title":"Therapeutic application of circular RNA aptamers in a mouse model of psoriasis","author":"Guo","year":"2024","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.drudis.2026.104609_b0315","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adl4336","article-title":"Dual-responsive nanocarriers for efficient cytosolic protein delivery and CRISPR-Cas9 gene therapy of inflammatory skin disorders","volume":"10","author":"Tan","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.drudis.2026.104609_b0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017160","article-title":"The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans","volume":"6","author":"Di Meglio","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2026.104609_b0325","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","article-title":"The biogenesis, biology and characterization of circular RNAs","volume":"20","author":"Kristensen","year":"2019","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.drudis.2026.104609_b0330","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1111\/all.15234","article-title":"Translation and emerging functions of non\u2010coding RNAs in inflammation and immunity","volume":"77","author":"Della Bella","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.drudis.2026.104609_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109766","article-title":"Circular RNA sequencing identified circARNTL2 as a pathogenic factor in psoriasis by facilitating proliferation and cell cycle progression of keratinocytes","volume":"255","author":"Zhang","year":"2023","journal-title":"Clin Immunol"},{"key":"10.1016\/j.drudis.2026.104609_b0340","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.drudis.2026.104609_b0345","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.drudis.2026.104609_b0350","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2022.01.008","article-title":"Non-viral vectors for RNA delivery","volume":"342","author":"Yan","year":"2022","journal-title":"J Control Release"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626000140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626000140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T15:02:03Z","timestamp":1774018923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644626000140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1359644626000140"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104609","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Achieving durable psoriasis remission with nucleic acid therapeutics","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104609","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104609"}}